Title: SR4
Official Title: 
Number of Sections: 1
Source: versions - SR4
Media Type: text/html

================================================================================

Section 1:
SR4 THE SENATE S.R. NO. 4 THIRTY-THIRD LEGISLATURE, 2025 STATE OF HAWAII SENATE RESOLUTION REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION. WHEREAS, the State has a duty to protect and improve the health and environment of the people; and WHEREAS, a number of state residents suffer from various mental health illnesses; and WHEREAS, according to an article published in Current Neuropharmacology, the use of ketamine is a valid antidepressant option for the treatment of treatment-resistant depression and has rapid antidepressant effects; and WHEREAS, Senate Bill No.     of the Thirty-Third Legislature of the State of Hawaii proposes to require insurance coverage for intravenous ketamine therapy; and WHEREAS, pursuant to section 23-51, Hawaii Revised Statutes, before any legislative measure that mandates health insurance coverage for specific health services, specific diseases, or certain providers of health care services as part of individual or group health insurance policies can be considered, concurrent resolutions shall be passed requesting the Auditor to prepare and submit to the Legislature a report that assesses both the social and financial effects of the proposed mandated coverage; now, therefore, BE IT RESOLVED by the Senate of the Thirty-third Legislature of the State of Hawaii, Regular Session of 2025, that the Auditor is requested to assess, pursuant to section 23-51, Hawaii Revised Statutes, both the social and financial effects of the proposed mandated health insurance coverage under Senate Bill No.     of the Thirty-third Legislature of the State of Hawaii, which requires insurance coverage for a percentage of the costs of intravenous ketamine therapy to treat depression; and BE IT FURTHER RESOLVED that the Auditor is requested to submit a report of the Auditor's findings and recommendations, including any proposed legislation, to the Legislature no later than twenty days prior to the convening of the Regular Session of 2026; and BE IT FURTHER RESOLVED that certified copies of this Resolution be transmitted to the Auditor and Insurance Commissioner. OFFERED BY: _____________________________ Report Title: Health; Medicaid; Insurance; Ketamine Therapy; Auditor; Report


================================================================================

Raw Text:
SR4 THE SENATE S.R. NO. 4 THIRTY-THIRD LEGISLATURE, 2025 STATE OF HAWAII SENATE RESOLUTION REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION. WHEREAS, the State has a duty to protect and improve the health and environment of the people; and WHEREAS, a number of state residents suffer from various mental health illnesses; and WHEREAS, according to an article published in Current Neuropharmacology, the use of ketamine is a valid antidepressant option for the treatment of treatment-resistant depression and has rapid antidepressant effects; and WHEREAS, Senate Bill No.     of the Thirty-Third Legislature of the State of Hawaii proposes to require insurance coverage for intravenous ketamine therapy; and WHEREAS, pursuant to section 23-51, Hawaii Revised Statutes, before any legislative measure that mandates health insurance coverage for specific health services, specific diseases, or certain providers of health care services as part of individual or group health insurance policies can be considered, concurrent resolutions shall be passed requesting the Auditor to prepare and submit to the Legislature a report that assesses both the social and financial effects of the proposed mandated coverage; now, therefore, BE IT RESOLVED by the Senate of the Thirty-third Legislature of the State of Hawaii, Regular Session of 2025, that the Auditor is requested to assess, pursuant to section 23-51, Hawaii Revised Statutes, both the social and financial effects of the proposed mandated health insurance coverage under Senate Bill No.     of the Thirty-third Legislature of the State of Hawaii, which requires insurance coverage for a percentage of the costs of intravenous ketamine therapy to treat depression; and BE IT FURTHER RESOLVED that the Auditor is requested to submit a report of the Auditor's findings and recommendations, including any proposed legislation, to the Legislature no later than twenty days prior to the convening of the Regular Session of 2026; and BE IT FURTHER RESOLVED that certified copies of this Resolution be transmitted to the Auditor and Insurance Commissioner. OFFERED BY: _____________________________ Report Title: Health; Medicaid; Insurance; Ketamine Therapy; Auditor; Report